Unfortunately, in many cases, the biochemical approach to disease, at best, can manage symptoms, and as a result, many conditions remain "incurable" while non-patentable natural therapies that can cure them languish in obscurity.

That's why, despite spending an ever increasing amount of money on Alzheimer's research (e.g., the NIH spent 2.9 billion in 2020 and 3.9 billion in 20241), we've still failed to make any real progress on the disease. This is particularly remarkable given the vast costs to the country (e.g., last year Alzheimer's was estimated to cost the United States 360 billion dollars2) and the even greater social costs that accompany it.